An Analysis of the Frequency and Progression of COVID-19 Infection in Women with Gestational Diabetes Mellitus Compared to Non-Diabetic Mellitus Pregnant Women

Authors

  • Inaam Faisal Mohammed College of Medicine, University of Diyala, Iraq Author
  • Nadia Hasan Hussein College of Medicine, University of Diyala, Iraq Author
  • Dalila Adil Hasan College of Medicine, University of Diyala, Iraq Author

DOI:

https://doi.org/10.59675/MU122

Keywords:

Assessment, Insulin Sensitivity, Insulin Resistance

Abstract

Background: The general population is less at risk for COVID-19 problems than pregnant women. COVID-19 severity may increase with gestational diabetes mellitus (GDM). This study examined COVID-19 incidence, clinical symptoms, and maternal and neonatal outcomes in pregnant women with and without GDM.

Methods: This retrospective cohort study examined 30 pregnant women aged 15-38 years with confirmed COVID-19 infection at a hospital in Iraq from September 2021 to March 2022. Participants were divided into a GDM group (n=15) and non-GDM group (n=15). COVID-19 symptoms, pregnancy complications, and maternal outcomes were recorded and compared between groups.

Results: COVID-19 infection occurred in 63.3% of the GDM group compared to 36.7% of the non-GDM group. Fever, cough, dyspnea, diarrhea, and constipation were the most common COVID-19 symptoms. The GDM group had higher rates of preterm delivery (31.6% vs 18.2%), abortion (21% vs 9.1%), hospital admission (47.4% vs 18.2%), and oxygen supplementation (21.1% vs 18.2%) compared to the non-GDM group.

Conclusions: Pregnant women with GDM exhibited a notably higher incidence of COVID-19 infection and experienced worse maternal and neonatal complications compared to those without diabetes. GDM represents an important risk factor for augmented COVID-19 severity and adverse pregnancy outcomes. These findings have implications for clinical monitoring and management of pregnant populations with GDM during the pandemic.

Downloads

Download data is not yet available.

References

WHO. Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/. 2021.

McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019 Jul 11;5(1):47. DOI: https://doi.org/10.1038/s41572-019-0098-8

Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021 Apr 19;193(16):E540-8. DOI: https://doi.org/10.1503/cmaj.202604

Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27. DOI: https://doi.org/10.1002/uog.22088

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020 Sep 1;8(9):782-92. DOI: https://doi.org/10.1016/S2213-8587(20)30238-2

Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020 Jul 1;14(4):535-45. DOI: https://doi.org/10.1016/j.dsx.2020.04.044

Anju M, Maiya AG, Hande M, Binu VS. Effect of photobiomodulation on serum neuron specific enolase (NSE) among patients with diabetic peripheral neuropathy–A pilot study. Diabetes Metab Syndr. 2020 Sep 1;14(5):1061-3. DOI: https://doi.org/10.1016/j.dsx.2020.06.065

Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, Alsukait RF, Alluhidan M, Alazemi N, Shekar M. Individuals with obesity and COVID‐19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov;21(11):e13128. DOI: https://doi.org/10.1111/obr.13128

Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020 Jun 1;8(6):546-50. DOI: https://doi.org/10.1016/S2213-8587(20)30152-2

Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A, Resnick R, Vanderhoeven J, Hwang JK, Barnhart N, Rah J. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2020 Dec 1;223(6):911.e1. DOI: https://doi.org/10.1016/j.ajog.2020.05.031

Toscano M, Royzer R, Castillo D, Li D, Poleshuck E. Prevalence of depression or anxiety during antepartum hospitalizations for obstetric complications: A systematic review and meta-analysis. Obstet Gynecol. 2021 May 5;137(5):881. DOI: https://doi.org/10.1097/AOG.0000000000004335

Kleinwechter HJ, Weber KS, Mingers N, Ramsauer B, Schaefer-Graf UM, Groten T, Kuschel B, Backes C, Banz-Jansen C, Berghaeuser MA, Brotsack IA. Gestational diabetes mellitus and COVID-19: results from the COVID-19–Related Obstetric and Neonatal Outcome Study (CRONOS). Am J Obstet Gynecol. 2022 Oct 1;227(4):631.e1. DOI: https://doi.org/10.1016/j.ajog.2022.05.027

Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K, Yue L, Li Q, Sun G, Chen L, Yang L. Maternal and neonatal outcomes of pregnant women with coronavirus disease 2019 (COVID-19) pneumonia: a case-control study. Clin Infect Dis. 2020 Oct 15;71(16):2035-41. DOI: https://doi.org/10.1093/cid/ciaa352

Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, Triebwasser JE, Gerber JS, Morris JS, Weirick ME, McAllister CM. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr. 2021 Jun 1;175(6):594-600. DOI: https://doi.org/10.1001/jamapediatrics.2021.0038

Rahnemaei FA, Pakzad R, Amirian A, Pakzad I, Abdi F. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis. Open Med (Wars). 2021 Dec 15;17(1):70-86. DOI: https://doi.org/10.1515/med-2021-0408

Albini A, Di Guardo G, Noonan DM, Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor-and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med. 2020 Aug;15:759-66. DOI: https://doi.org/10.1007/s11739-020-02364-6

Published

25-12-2023

Issue

Section

Articles

How to Cite

Inaam Faisal Mohammed, Nadia Hasan Hussein, & Dalila Adil Hasan. (2023). An Analysis of the Frequency and Progression of COVID-19 Infection in Women with Gestational Diabetes Mellitus Compared to Non-Diabetic Mellitus Pregnant Women. Academic International Journal of Medical Update, 1(2), 10-20. https://doi.org/10.59675/MU122
Views: 33 / Download: 7